Non-invasive blood glucose measurement using Raman spectroscopy on the fingernail
Official title: Clinical Study of Non-invasive Blood Glucose Detection Technology Based on Raman Spectroscopy
Run by Beijing Shijitan Hospital, Capital Medical University · NCT07311421 · Data updated 2026-11-12
This project tests a Raman spectroscopy method to painlessly measure blood glucose in adults with diabetes and healthy volunteers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 49 (estimated) |
| Sponsor | Beijing Shijitan Hospital, Capital Medical University Academic / other |
| Locations | 2 sites (Beijing, Beijing Municipality and 1 other locations) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | June 10, 2026 |
| Study ends | October 31, 2026 |
| Registry record updated | December 31, 2025 |
| Trial ID | NCT07311421 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–75 years old with diagnosed diabetes or healthy volunteers who have intact, product‑free nails and can attend in‑person visits at the Beijing site are ideal candidates.
✕Probably not a fit
People with nail infections or damage, recent use of nail polish or artificial nails, pregnant or lactating women, those with serious terminal illnesses or severe mental illness, or anyone unable to complete study procedures are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project collects Raman spectra from participants' nails to derive blood glucose estimates without finger pricks. Adults aged 18–75, including people with diagnosed diabetes and healthy volunteers, will be scanned at Beijing Shijitan Hospital and provide standard capillary or venous glucose measurements for comparison. Participants with nail disease, recent use of nail products, pregnancy, severe chronic illness, or inability to complete procedures will be excluded to avoid confounding the optical measurements. The study compares Raman-derived glucose values with conventional measurements to characterize accuracy and clinical feasibility.
Why it matters
Potential benefit: If successful, this could offer a painless, convenient way to monitor blood glucose without finger‑prick tests.
How similar studies have gone: Laboratory studies and small pilot reports have shown promising accuracy for Raman-based glucose detection, but larger clinical validation in real-world cohorts is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Age range: 18-75 years old. Gender: unlimited. Health status: patients with diagnosed diabetes or healthy volunteers. Nail health status: no obvious infection, discoloration, peeling and other lesions of the nail, so as to ensure the accuracy of Raman spectroscopy measurement. Willing to participate in the study and sign the informed consent. Exclusion Criteria: Nail diseases: such as fungal infections, psoriasis, trauma resulting in nail damage or deformity. The presence of factors that influenced the measurement results: Participants who used nail polish, fake nails, or nail products. Recent use of drugs containing heavy metals (which may affect nail composition) and skin conditions are not appropriate for such tests. Pregnant or lactating women. People with serious chronic diseases (such as terminal cancer, end-stage renal disease) or mental illness. Non-cooperation or inability to complete the entire research process, such as refusal or inability to complete Raman spectrum acquisition.
Where it's running
-
Beijing Shijitan Hospital
Beijing, Beijing Municipality, China Recruiting -
Beijing Shijitan Hospital
Haidian, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Yuanyuan Miao
- Email: miaoyuanyuan1001@163.com
- Phone: +86 18815015576
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Improving Care for underserved older Black patients with cardiovascular and other chronic conditions
This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
-
Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes
A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.
-
Polypill Approach for Multiple Cardiovascular Risk Factors
Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.